Surrey Heartlands

Joint Formulary & PAD

Baricitinib - Alopecia

You are here : Home > Formulary Search > Baricitinib - Alopecia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
NFD1
NICE
Restrictions / Comments :
Documents :
 
Webpage
Baricitinib for treating severe alopecia areata NICE TA926

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Baricitinib
Indication :
Alopecia
Group Name :
Keywords :
alopecia areata, NICE,
Brand Names Include :
Olumiant
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Baricitinib is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Alopecia.

Committee Recommendations (1)

01 Nov 23 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed that baricitinib for severe alopecia areata will be given a NON-FORMULARY traffic light status following publication of NICE TA926.

Baricitinib is not recommended, by NICE, within its marketing authorisation, for treating this indication.